RT Journal Article
SR Electronic
T1 A pathologist's survey on the reporting of sessile serrated adenomas/polyps
JF Journal of Clinical Pathology
JO J Clin Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP 426
OP 430
DO 10.1136/jclinpath-2013-202128
VO 67
IS 5
A1 Chetty, Runjan
A1 Bateman, Adrian C
A1 Torlakovic, Emina
A1 Wang, Lai Mun
A1 Gill, Pelvender
A1 Al-Badri, Adnan
A1 Arends, Mark
A1 Biddlestone, Leigh
A1 Burroughs, Susan
A1 Carey, Frank
A1 Cowlishaw, David
A1 Crowther, Stephen
A1 Da Costa, Philip
A1 Dada, Mahomed A
A1 d'Adhemar, Charles
A1 Dasgupta, Kaushik
A1 de Cates, Chandima
A1 Deshpande, Vikram
A1 Feakins, Roger M
A1 Foria, Bineeta
A1 Foria, Vipul
A1 Fuller, Clare
A1 Green, Bryan
A1 Greenson, Joel K
A1 Griffiths, Paul
A1 Hafezi-Bakhtiari, Sara
A1 Henry, James
A1 Jaynes, Eleanor
A1 Jeffers, Michael D
A1 Kaye, Philip
A1 Landers, Robert
A1 Lauwers, Gregory Y
A1 Loughrey, Maurice
A1 Mapstone, Nicholas
A1 Novelli, Marco
A1 Odze, Robert
A1 Poller, David
A1 Rowsell, Corwyn
A1 Sanders, Scott
A1 Sarsfield, Patrick
A1 Schofield, John B
A1 Sheahan, Kieran
A1 Shepherd, Neil
A1 Sherif, Ali
A1 Sington, James
A1 Walsh, Shaun
A1 Williams, Namor
A1 Wong, Newton
YR 2014
UL http://jcp.bmj.com/content/67/5/426.abstract
AB Aim The purpose of this survey was to ascertain reporting habits of pathologists towards sessile serrated adenomas/polyps (SSA/P). Methods A questionnaire designed to highlight diagnostic criteria, approach and clinical implications of SSA/P was circulated electronically to 45 pathologists in the UK and North America. Results Forty-three of 45 pathologists agreed to participate. The vast majority (88%) had a special interest in gastrointestinal (GI) pathology, had great exposure to GI polyps in general with 40% diagnosing SSA/P at least once a week if not more, abnormal architecture was thought by all participants to be histologically diagnostic, and 11% would make the diagnosis if a single diagnostic histological feature was present in one crypt only, while a further 19% would diagnose SSA/P in one crypt if more than one diagnostic feature was present. The vast majority agreed that deeper sections were useful and 88% did not feel proliferation markers were useful. More than one-third did not know whether, or did not feel that, their clinicians were aware of the implications of SSA/P. Conclusions 98% of pathologists surveyed are aware that SSA/P is a precursor lesion to colorectal cancer, the majority agree on diagnostic criteria, and a significant number feel that there needs to be greater communication and awareness among pathologists and gastroenterologists about SSA/P.